Try a new search

Format these results:

Searched for:

in-biosketch:yes

person:rotroj01

Total Results:

383


LECITHIN AND PIRACETAM IN ALZHEIMERS-DISEASE

SERBY, M; CORWIN, J; ROTROSEN, J; FERRIS, SH; REISBERG, B; FRIEDMAN, E; SHERMAN, KA; JORDAN, B; BARTUS, R
ISI:A1983PY52700045
ISSN: 0048-5764
CID: 40574

Red cell phospholipids in schizophrenia

Lautin A; Cordasco DM; Segarnick DJ; Wood L; Mason MF; Wolkin A; Rotrosen J
Phospholipids in red blood cells (RBCs) of schizophrenics and controls were determined. Three different RBC preparations and two different extraction methods were used. Phospholipids were separated by thin layer chromatography and by high pressure liquid chromatography, and were quantified by phosphorus analysis and by ultraviolet absorption. Findings were consistent with values previously reported for normals. However, in contrast to recent reports of elevated phosphatidylserine levels in schizophrenics' RBCs, we observed no differences between populations
PMID: 7162365
ISSN: 0024-3205
CID: 23640

The Benzamides : pharmacology, neurobiology, and clinical aspects

Stanley, Michael; Rotrosen, John
New York : Raven Press, c1982
Extent: xii, 209 p. : ill. ; 27 cm
ISBN: n/a
CID: 106

Partial improvement in negative schizophrenic symptoms after amphetamine

Angrist B; Peselow E; Rubinstein M; Corwin J; Rotrosen J
In stable schizophrenic outpatients with predominantly 'defect state' symptomatology amphetamine caused a reduction in negative symptoms that was statistically significant but not complete (i.e. these symptoms remained clinically discernible). The possibility that dopaminergic hypofunction contributes some elements to the schizophrenic defect state is presented, along with some limited data compatible with this concept. These findings are compared to prior studies in recently hospitalized schizophrenic subjects, and discussed with respect to recent theoretical concepts regarding the role of dopamine in schizophrenic psychopathology
PMID: 6817367
ISSN: 0033-3158
CID: 23641

Piracetam reduces alcohol withdrawal in mice without potentiating alcohol sedative effects

Serby M; Segarnick DJ; Cordasco DM; Rotrosen J
PMID: 6758623
ISSN: 0145-6008
CID: 23642

The benzamides: evidence for action at dopamine receptors--shortcomings of current models

Wazer DE; Rotrosen J; Stanley M
PMID: 6756063
ISSN: 0065-2229
CID: 23643

Biochemical and behavioral interactions between prostaglandin E-1 and alcohol

Chapter by: Segarnick, D.J.; Cordasco, D.M.; Rotrosen, J
in: Clinical uses of essential fatty acids : proceedings of the First Efamol Symposium, held in London, England in November, 1981 by Horrobin, David F [Eds]
Montreal : Eden Press, c1982
pp. P175-P190
ISBN: 9780920792230
CID: 761602

Effect of cycloheximide on corticosteroid-induced changes in

Zorgniotti, A W; Adler, L; Peselow, E; Corwin, J; Rotrosen, J University Medical Center and Psychiatry Service, Veterans Administration Medical Center, New York, NY 10016 United States; Aleksic, S; Greco, M A; Reuben, R; Margolis, S; Epstein, F; Feigin, I; Charney, A N; Wallach, J D; Donowitz, M; Johnstone, N
13 cases of Goldenhar-Gorlin syndrome are presented in which numerous central nervous system anomalies have been found. These others. Pertinent literature has been reviewed. It is concluded that any part of the central nervous system can be involved in this condition and that careful evaluation is indicated in order to rule
EMBASE:22024188
ISSN: 0007-1250
CID: 4775032

Human platelet phospholipid methylation

Cordasco DM; Segarnick DJ; Rotrosen J
PMID: 6798348
ISSN: 0024-3205
CID: 23644

Effect of lithium on glycine levels in patients with affective disorders

Deutsch SI; Peselow ED; Banay-Schwartz M; Gershon S; Virgilio J; Fieve RR; Rotrosen J
PMID: 6786113
ISSN: 0002-953x
CID: 23645